Ekberg M, Pandolfi M
Br Med J. 1975 Apr 5;2(5961):17-9. doi: 10.1136/bmj.2.5961.17.
To elucidate the origin of the fibrin/fibrinogen degradation products (F.D.P.) occurring in the urine in glomerulonephritis 28 patients with glomerulonephritis were examined for renal fibrinolytic activity, F.D.P. in urine and serum, and blood fibrinolytic activators and blood fibrinolytic activators and inhibitors. Unlike the glomerful of healthy kidneys, which were fibrinolyticly inactive, those of kidneys with glomerulonephritis constantly showed fibrinolytic activity. The presence or absence of fibrin in the glomeruli was almost always accompanied by, respectively, the presence or absence of urinary F.D.P., which suggested a renal origin of urinary F.D.P. in glomerulonephritis. The low fibrinolytic activity of the blood and the absence of F.D.P. in the serum of these patients make it unlikely that the urinary F.D.P. in glomerulonephritis result from glomerular filtration.
为阐明肾小球肾炎患者尿中纤维蛋白/纤维蛋白原降解产物(F.D.P.)的来源,对28例肾小球肾炎患者进行了肾纤维蛋白溶解活性、尿和血清中的F.D.P.以及血液纤维蛋白溶解激活剂和抑制剂的检测。与健康肾脏的肾小球无纤维蛋白溶解活性不同,肾小球肾炎患者的肾小球持续显示出纤维蛋白溶解活性。肾小球中纤维蛋白的有无几乎总是分别伴随着尿中F.D.P.的有无,这提示肾小球肾炎患者尿中F.D.P.来源于肾脏。这些患者血液纤维蛋白溶解活性低且血清中无F.D.P.,这使得肾小球肾炎患者尿中F.D.P.不太可能是由肾小球滤过产生的。